Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658466 | SCV000780238 | uncertain significance | not provided | 2024-02-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001082525 | SCV001096629 | likely benign | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002534289 | SCV003733159 | uncertain significance | Inborn genetic diseases | 2022-08-11 | criteria provided, single submitter | clinical testing | The c.2350A>G (p.M784V) alteration is located in exon 14 (coding exon 14) of the EVC2 gene. This alteration results from a A to G substitution at nucleotide position 2350, causing the methionine (M) at amino acid position 784 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |